The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence of PI3K pathway alteration and response to neoadjuvant therapy (NAT) in triple negative breast cancer (TNBC) subtypes.
 
Reva K Basho
Employment - Alignment Healthcare (I); Castlewood Treatment Center (I); DaVita (I)
Consulting or Advisory Role - Genomic Health; Puma Biotechnology (Inst)
Speakers' Bureau - Genentech
Research Funding - Seagen (Inst)
 
Clinton Yam
No Relationships to Disclose
 
Jason B White
Employment - AstraZeneca/MedImmune
Patents, Royalties, Other Intellectual Property - Two patents pending at AstraZeneca/Medimmune related to antibody-drug conjugate technology.
 
Li Zhao
No Relationships to Disclose
 
Lei Huo
No Relationships to Disclose
 
Elizabeth A. Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Genomic Health; Merck; Merck; Peregrine Pharmaceuticals; Sellas Life Sciences; TapImmune Inc.
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Galena Biopharma (Inst); Genentech/Roche (Inst); GlaxoSmithKline
 
Alastair Mark Thompson
Honoraria - Novartis (I); Pfizer
Travel, Accommodations, Expenses - Novartis (I); Pfizer
 
Jennifer Keating Litton
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Medivation/Pfizer; Pfizer
Speakers' Bureau - Clinical Care Options; Med Learning Group; Medpage; Medscape; Physicans' Education Resource; Prime Oncology; UpToDate
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Medivation/Pfizer (Inst); Novartis (Inst); pfizer (Inst); Zenith Epigenetics (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Clinical Care Options; Med Learning Group; Medscape; Physicans' Education Resource
Other Relationship - Medivation/Pfizer
 
Banu Arun
Consulting or Advisory Role - Abbvie; Bright Pink
Research Funding - Abbvie (Inst); AstraZeneca (Inst); InVitae (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Bora Lim
Consulting or Advisory Role - AstraZeneca; Lilly; Natera; Novartis
Research Funding - Calithera Biosciences; Genentech; Merck; Puma Biotechnology; Takeda
 
Vicente Valero
Honoraria - Genentech/Roche
Consulting or Advisory Role - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Debu Tripathy
Consulting or Advisory Role - Genomic Health; GlaxoSmithKline; Nektar; Novartis; Pfizer; Polyphor; Sellas Life Sciences
Research Funding - Novartis (Inst); Polyphor (Inst)
Travel, Accommodations, Expenses - Novartis
 
Jianhua Zhang
No Relationships to Disclose
 
Beatriz E Adrada
No Relationships to Disclose
 
Lumarie Santiago
No Relationships to Disclose
 
Elizabeth Ravenberg
No Relationships to Disclose
 
Stacy L. Moulder
Research Funding - Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)
 
Senthil Damodaran
Honoraria - Novartis
Consulting or Advisory Role - Pfizer; Taiho Pharmaceutical; Tempus
Research Funding - EMD Serono (Inst); Guardant Health (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Phillips Gilmore Oncology Communications